📉 The Financial Deep Dive
Signatureglobal (India) Limited has revealed a significant downturn for the nine months ended December 31, 2025 (9M'FY26). The company’s recognized revenue plummeted 25% year-on-year to INR 14.9 billion, a sharp fall from INR 19.8 billion in 9M'FY25. This revenue decline was attributed to project completion schedules, though management maintains core business fundamentals are robust.
Profitability metrics show considerable pressure. Adjusted EBITDA margins contracted severely to 4.1% in 9M'FY26, down from 11.6% in the prior year. Consequently, the company posted a net loss of INR 0.6 billion for the period, a stark contrast to the net profit of INR 0.4 billion recorded in 9M'FY25. A silver lining, however, was the improvement in Adjusted Gross Margin to 31.1% from 26.9%, driven by sales in premium markets and price increases.
📊 Financial Health & Outlook
On the balance sheet front, net debt escalated to INR 10.2 billion as of December 31, 2025, an increase from INR 8.8 billion at the close of March 2025. The company targets keeping its net debt below 0.5 times its projected operating surplus.
For the full fiscal year 2026 (FY26), Signatureglobal has projected revenue recognition of INR 48 billion and set an ambitious pre-sales target of INR 125 billion. The company expanded its portfolio by launching two premium projects, Cloverdale and Sarvam, during the nine-month period, adding approximately 2.3 million sqft.
🚩 Risks & Management Commentary
Management acknowledges facing headwinds, noting "muted pre-sales due to overall market turning softer." Despite this, they expect collections to improve and business momentum to build in the upcoming quarters, underpinned by project completions. The company also secured a CARE rating of A+ stable for its Non-Convertible Debenture (NCD) issuance, indicating some financial confidence from rating agencies.